Vaccination; Infection Clinical Trials
2 recruiting trials for Vaccination; Infection. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Vaccination; Infection clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by National Taiwan University Hospital (1), Centre Hospitalier Universitaire de Nice (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is recombinant hepatitis B vaccine (biological, 1 trial), followed by Vaccine injection.
Track Vaccination; Infection trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults...
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
Immune response to influenza vaccine in patients with chronic renal insufficiency.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Vaccination; Infection, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Vaccination; Infection, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Vaccination; Infection, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.